DFTX
Definium Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.06
+0.08 ▲ +0.44%
🌙 3월 13일 7:52 PM ET (한국 3/14 08:52)
$17.89
-0.17 ▼ -0.96%
| Index | RUT | P/E | - | EPS (ttm) | -2.07 | Insider Own | 5.36% | Shs Outstand | 0.10B | Perf Week | 2.27% |
| Market Cap | 1.80B | Forward P/E | - | EPS next Y | 3.06% | Insider Trans | -1.61% | Shs Float | 0.09B | Perf Month | 4.09% |
| Enterprise Value | 1.43B | PEG | - | EPS next Q | -0.48 | Inst Own | 66.4% | Short Float | 20.5% | Perf Quarter | 45.88% |
| Income | -0.18B | P/S | - | EPS this Y | 8.67% | Inst Trans | - | Short Ratio | 10.09 | Perf Half Y | 87.15% |
| Sales | 0.00B | P/B | 5.37 | EPS next 5Y | 35.97% | ROA | -49.52% | Short Interest | 19.34M | Perf YTD | 34.88% |
| Book/sh | 3.36 | P/C | 4.37 | EPS past 3/5Y | -3.78% -1.48% | ROE | -64.06% | 52W High | -7.95% ($19.62) | Perf Year | 186.21% |
| Cash/sh | 4.13 | P/FCF | - | Sales past 3/5Y | - | ROIC | -49.29% | 52W Low | 284.26% ($4.70) | Perf 3Y | 496.04% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -14.47% | Gross Margin | - | Volatility(W/M) | 5.69% 6.1% | Perf 5Y | -57% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.29 | EPS Q/Q | -23.36% | Profit Margin | - | RSI (14) | 56.06 | Recom | 1.07 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.29 | Sales Q/Q | - | SMA20 | 2.88% ($17.55) | Beta | 2.64 | Target Price | $34.14 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 2000000 | SMA50 | 8.81% ($16.6) | Rel Volume | 0.85 | Prev Close | $17.98 |
| Employees | 106 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | -5.44% - | SMA200 | 52.33% ($11.86) | Avg Volume(3M) | 1.92M | Price | $18.06 |
| IPO | 2016/11/15 | Option/Short | Yes/Yes | Trades | 12818 | Volume | 1,628,774 | Change | 0.44% |
뉴스 로딩 중...